We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-6.51%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$30.3M
AUM Growth
-$8.82M
Cap. Flow
-$4.3M
Cap. Flow %
-14.18%
Top 10 Hldgs %
82.87%
Holding
23
New
4
Increased
3
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$941K
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$744K
3
ADMS
Adamas Pharmaceuticals
ADMS
+$387K
4
YARW
Yarrow Bioscience
YARW
+$163K

Top Sells

Rank Stock Value
1
WBA
Walgreens Boots Alliance
WBA
+$2.12M
2
CVS icon
CVS Health
CVS
+$1.62M
3
COR icon
Cencora
COR
+$1.51M
4
CAH icon
Cardinal Health
CAH
+$1.28M

Sector Composition

Rank Sector Weight
1 Healthcare 80.93%
2 Miscellaneous 17.22%
3 Consumer Staples 1.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GSK icon
1
GSK
GSK
$101B
$3.76M 12.4%
80,000
– –
JAZZ icon
2
Jazz Pharmaceuticals
JAZZ
$16.3B
$3.56M 11.75%
25,000
+6,000
+32% +$744K
GILD icon
3
Gilead Sciences
GILD
$185B
$3.16M 10.41%
50,000
– –
ABBV icon
4
AbbVie
ABBV
$456B
$3.07M 10.1%
35,000
+10,000
+40% +$941K
YARW
5
Yarrow Bioscience
YARW
$104M
$2.99M 9.85%
500
+28
+6% +$163K
SPXU icon
6
ProShares UltraPro Short S&P 500
SPXU
$384M
$2.17M 7.17%
2,500
– –
TYME
7
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2.13M 7.03%
2,175,000
– –
MCK icon
8
McKesson
MCK
$104B
$1.49M 4.91%
10,000
– –
CLVS
9
DELISTED
Clovis Oncology, Inc.
CLVS
$1.46M 4.8%
250,000
– –
ATRS
10
DELISTED
Antares Pharma, Inc.
ATRS
$1.35M 4.45%
500,000
– –
CAH icon
11
Cardinal Health
CAH
$54.6B
$1.17M 3.87%
25,000
-25,000
-50% -$1.28M
SPXU icon
12
CALL
ProShares UltraPro Short S&P 500
SPXU
$384M
$870K 2.87%
1,000
-1,000
-50% -$940K
MRNA icon
13
PUT
Moderna
MRNA
$57.1B
$708K 2.33%
+10,000
New +$697K
GNLN icon
14
Greenlane Holdings
GNLN
$1.95M
– –
0
– –
NVAX icon
15
PUT
Novavax
NVAX
$1.49B
$542K 1.79%
+5,000
New +$609K
VIXY icon
16
CALL
ProShares VIX Short-Term Futures ETF
VIXY
$212M
$510K 1.68%
+313
New +$570K
AMRN
17
CALL
Amarin Corp
AMRN
$297M
$421K 1.39%
5,000
– –
ADMS
18
DELISTED
Adamas Pharmaceuticals
ADMS
$412K 1.36%
+100,000
New +$387K
COR icon
19
Cencora
COR
$61.3B
– –
-15,000
Closed -$1.51M
CVS icon
20
CVS Health
CVS
$119B
– –
-25,000
Closed -$1.62M
VKTX icon
21
CALL
Viking Therapeutics
VKTX
$3.95B
– –
-100,000
Closed -$721K
WBA
22
DELISTED
Walgreens Boots Alliance
WBA
– –
-50,000
Closed -$2.12M
CLVS
23
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-100,000
Closed -$675K

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q3 2020 Portfolio in Review

As of Q3 2020, Healthcare Value Capital held 23 positions worth $30.3M, down 23% from $39.2M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Healthcare Value Capital withdrew a net $4.3M in Q3 2020, closing 5 positions and reducing 2 holdings. Its most notable exit was Walgreens Boots Alliance, an estimated $2.12M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 79% a quarter earlier, followed by Miscellaneous and Consumer Staples.

Against the trend, Healthcare Value Capital opened a new position in Adamas Pharmaceuticals worth $412K.

  • Healthcare Value Capital's largest Q3 2020 buy was Adamas Pharmaceuticals: 100,000 shares worth $412K.
  • Healthcare Value Capital added most to AbbVie in Q3 2020, an estimated $941K increase.
  • Healthcare Value Capital's biggest Q3 2020 reduction was Cardinal Health, cutting an estimated $1.28M.
  • Healthcare Value Capital fully exited Walgreens Boots Alliance in Q3 2020, selling an estimated $2.12M.
  • Healthcare Value Capital's ten largest holdings make up 83% of its $30.3M portfolio in Q3 2020.
  • Healthcare Value Capital opened 4 new positions and closed 5 in Q3 2020.
  • Healthcare Value Capital's portfolio value fell 23% quarter-over-quarter to $30.3M.

Based on Healthcare Value Capital's 13F filing for Q3 2020, filed 16 Nov 2020.